Clearview Wealth Advisors LLC Synthetic Biologics, Inc. Transaction History

Clearview Wealth Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$2.7 - $4.5 $55,128 - $91,881	-20,418 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$4.3 - $5.8 $8,638 - $11,652	2,009 Added 10.91%	20,418 $9,000
Q2 2021 Jul 30, 2021	BUY	$4.6 - $7.2 $84,681 - $132,544	18,409 New	18,409 $11,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.